Julia H Arnsten
Datos Biográficos
| ID | 7180253 |
|---|---|
| NOMBRE | Julia H Arnsten |
| NOMBRES | Julia H |
| APELLIDO | Arnsten |
| FIRMA | ARNSTEN J H |
| AFILIACIONES | Albert Einstein College of Medicine |
| ORCID | 0000-0002-7741-1567 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 24 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 24 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2001 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on Covid-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C
Greater SDoH difficulties and lower self-efficacy were associated with greater inability to practice COVID-19 personal protective behaviors. Interventions to meet SDoH-related challenges and increase self-efficacy could help encourage practice of personal protective behaviors and economically reduce disease burden during health crises
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs
Feasibility and acceptability of a peer influencer delivered social media based intervention to promote mental health awareness for young Black and Latinx gay and bisexual men and transgender women
Using an intervention informed and delivered by PIs, participants were presented with information to address relevant mental health concerns. We found that such novel means of engaging this sample for mental health is feasible, acceptable, and merits further development
Preliminary Evidence of the Association between Time on Buprenorphine and Cognitive Performance among Individuals with Opioid Use Disorder Maintained on Buprenorphine
People on buprenorphine maintenance treatment (BMT) commonly present cognitive deficits that have been associated with illicit drug use and dropout from buprenorphine treatment. This study has compared cognitive responses to the Stroop Task and the Continuous Performance Task (CPT) among individuals on BMT, with recent drug use, and healthy controls and explored the associations between cognitive responses and drug use, craving, and buprenorphine…
HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy
Among people who inject drugs (PWID), 60% have HCV and 50–90% of HIV-infected PWID are co-infected with HCV. Data comparing adherence to direct-acting antiviral (DAA) therapy among HCV mono-infected and HIV/HCV co-infected PWID is limited. The impact of HCV treatment initiation on HIV antiretroviral therapy (ART) adherence is also poorly understood. We assessed DAA adherence in HCV mono-infected and HIV/HCV co-infected PWID and examined changes i…
Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaine
Disparities remain in HIV viral load (VL) suppression between people living with HIV (PLWH) who use cocaine and those who do not. It is not known how cannabis use affects VL suppression in PLWH who use cocaine. We evaluated the relationship between cannabis use and VL suppression among PLWH who use cocaine. We conducted a secondary data analysis of 119 baseline interviews from a randomized controlled trial in the Bronx, NY (6/2012 to 1/2017). Par…
How medical are states’ medical cannabis policies
High HCV cure rates among people who inject drugs and have suboptimal adherence
Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs
Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary
Medical cannabis patients consistently report using cannabis as a substitute for prescription medications; however, little is known about individuals accessing cannabis through adult-use markets. A survey at two retail stores was conducted in Colorado, United States. Between August 2016 and October 2016, store staff asked customers if they wanted to participate and, if so, provided an electronic survey link. All customers reporting medical certif…
Feasibility and Preliminary Effectiveness of Varenicline for Treating Co-Occurring Cannabis and Tobacco Use
Few studies have evaluated treatment for co-occurring cannabis and tobacco use. The objective of this pilot study was to evaluate the feasibility and preliminary effectiveness of varenicline for co-occurring cannabis and tobacco use. Participants who reported cannabis use on ≥5 days per week were recruited from an urban, outpatient opioid treatment program (OTP). Participants were randomized to either four weeks of standard OTP clinical care (SCC…
The Validity of Self-Reported Medication Adherence as an Outcome in Clinical Trials of Adherence-Promotion Interventions
“Damaging what wasn't damaged already”
Active drug use among HIV-infected persons is associated with poor adherence to highly active antiretroviral therapy (HAART) and suboptimal treatment outcomes. To understand adherence experiences among HIV-infected drug users, we conducted semistructured interviews with 15 participants in a randomized controlled trial evaluating the efficacy of directly observed HAART delivered in methadone maintenance clinics. Interviews were recorded, transcrib…
The Association Between Poor Antiretroviral Adherence and Unsafe Sex
Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users
Adherence counseling can improve antiretroviral adherence and related health outcomes in HIV-infected individuals. However, little is known about how much counseling is necessary to achieve clinically significant effects. We investigated antiretroviral adherence and HIV viral load relative to the number of hours of adherence counseling received by 60 HIV-infected drug users participating in a trial of directly observed antiretroviral therapy deli…
Association Between Use of Specific Drugs and Antiretroviral Adherence
Comparison of Antiretroviral Adherence Questions
Self-efficacy and depression as mediators of the relationship between pain and antiretroviral adherence
The goals of this study were to examine the association between pain and antiretroviral adherence and to estimate the mediating effect of adherence self-efficacy and depression symptom severity. Surveys using audio computer-assisted self-interview were conducted among 70 HIV-infected current and former drug users enrolled in a methadone program. We assessed antiretroviral adherence and adherence self-efficacy using questions from the Adult Clinic…
Predictors of Current Housing Status Among HIV-Seropositive Injection Drug Users (IDUs)
Self-Report Adherence Measures in Chronic Illness
BACKGROUND: Patient self-report is a practical method for measuring adherence, but little is known about its optimal use. OBJECTIVES: To examine the retest reliability and predictive validity of 3 different types of self-report adherence measures among patients with common chronic illnesses. RESEARCH DESIGN: Correlation and regression analyses of data from an ongoing randomized controlled trial. SUBJECTS: Patients (N = 415) aged >or=40 years recr…
Practical and Conceptual Challenges in Measuring Antiretroviral Adherence
Accurate measurement of antiretroviral adherence is essential for targeting and rigorously evaluating interventions to improve adherence and prevent viral resistance. Across diseases, medication adherence is an individual, complex, and dynamic human behavior that presents unique measurement challenges. Measurement of medication adherence is further complicated by the diversity of available measures, which have different utility in clinical and re…
Providers’ HIV Prevention Discussions with HIV-Seropositive Injection Drug Users
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
Antiretroviral Therapy Adherence and Viral Suppression in HIV‐Infected Drug Users
To compare electronically monitored (MEMS) with self-reported adherence in drug users, including the impact of adherence on HIV load, we conducted a 6-month observational study of 67 antiretroviral-experienced current and former drug users. Adherence (percentage of doses taken as prescribed) was calculated for both the day and the week preceding each of 6 research visits. Mean self-reported 1-day adherence was 79% (median, 86%), and mean self-rep…
Sin obras prominentes en esta página.
Antiretroviral Therapy Adherence and Viral Suppression in HIV‐Infected Drug Users
To compare electronically monitored (MEMS) with self-reported adherence in drug users, including the impact of adherence on HIV load, we conducted a 6-month observational study of 67 antiretroviral-experienced current and former drug users. Adherence (percentage of doses taken as prescribed) was calculated for both the day and the week preceding each of 6 research visits. Mean self-reported 1-day adherence was 79% (median, 86%), and mean self-rep…
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
Practical and Conceptual Challenges in Measuring Antiretroviral Adherence
Accurate measurement of antiretroviral adherence is essential for targeting and rigorously evaluating interventions to improve adherence and prevent viral resistance. Across diseases, medication adherence is an individual, complex, and dynamic human behavior that presents unique measurement challenges. Measurement of medication adherence is further complicated by the diversity of available measures, which have different utility in clinical and re…
Providers’ HIV Prevention Discussions with HIV-Seropositive Injection Drug Users
Predictors of Current Housing Status Among HIV-Seropositive Injection Drug Users (IDUs)
Self-Report Adherence Measures in Chronic Illness
BACKGROUND: Patient self-report is a practical method for measuring adherence, but little is known about its optimal use. OBJECTIVES: To examine the retest reliability and predictive validity of 3 different types of self-report adherence measures among patients with common chronic illnesses. RESEARCH DESIGN: Correlation and regression analyses of data from an ongoing randomized controlled trial. SUBJECTS: Patients (N = 415) aged >or=40 years recr…
Self-efficacy and depression as mediators of the relationship between pain and antiretroviral adherence
The goals of this study were to examine the association between pain and antiretroviral adherence and to estimate the mediating effect of adherence self-efficacy and depression symptom severity. Surveys using audio computer-assisted self-interview were conducted among 70 HIV-infected current and former drug users enrolled in a methadone program. We assessed antiretroviral adherence and adherence self-efficacy using questions from the Adult Clinic…
Comparison of Antiretroviral Adherence Questions
Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users
Adherence counseling can improve antiretroviral adherence and related health outcomes in HIV-infected individuals. However, little is known about how much counseling is necessary to achieve clinically significant effects. We investigated antiretroviral adherence and HIV viral load relative to the number of hours of adherence counseling received by 60 HIV-infected drug users participating in a trial of directly observed antiretroviral therapy deli…
Association Between Use of Specific Drugs and Antiretroviral Adherence
“Damaging what wasn't damaged already”
Active drug use among HIV-infected persons is associated with poor adherence to highly active antiretroviral therapy (HAART) and suboptimal treatment outcomes. To understand adherence experiences among HIV-infected drug users, we conducted semistructured interviews with 15 participants in a randomized controlled trial evaluating the efficacy of directly observed HAART delivered in methadone maintenance clinics. Interviews were recorded, transcrib…
The Association Between Poor Antiretroviral Adherence and Unsafe Sex
The Validity of Self-Reported Medication Adherence as an Outcome in Clinical Trials of Adherence-Promotion Interventions
Feasibility and Preliminary Effectiveness of Varenicline for Treating Co-Occurring Cannabis and Tobacco Use
Few studies have evaluated treatment for co-occurring cannabis and tobacco use. The objective of this pilot study was to evaluate the feasibility and preliminary effectiveness of varenicline for co-occurring cannabis and tobacco use. Participants who reported cannabis use on ≥5 days per week were recruited from an urban, outpatient opioid treatment program (OTP). Participants were randomized to either four weeks of standard OTP clinical care (SCC…
Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs
Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary
Medical cannabis patients consistently report using cannabis as a substitute for prescription medications; however, little is known about individuals accessing cannabis through adult-use markets. A survey at two retail stores was conducted in Colorado, United States. Between August 2016 and October 2016, store staff asked customers if they wanted to participate and, if so, provided an electronic survey link. All customers reporting medical certif…
Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaine
Disparities remain in HIV viral load (VL) suppression between people living with HIV (PLWH) who use cocaine and those who do not. It is not known how cannabis use affects VL suppression in PLWH who use cocaine. We evaluated the relationship between cannabis use and VL suppression among PLWH who use cocaine. We conducted a secondary data analysis of 119 baseline interviews from a randomized controlled trial in the Bronx, NY (6/2012 to 1/2017). Par…
How medical are states’ medical cannabis policies
High HCV cure rates among people who inject drugs and have suboptimal adherence
HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy
Among people who inject drugs (PWID), 60% have HCV and 50–90% of HIV-infected PWID are co-infected with HCV. Data comparing adherence to direct-acting antiviral (DAA) therapy among HCV mono-infected and HIV/HCV co-infected PWID is limited. The impact of HCV treatment initiation on HIV antiretroviral therapy (ART) adherence is also poorly understood. We assessed DAA adherence in HCV mono-infected and HIV/HCV co-infected PWID and examined changes i…
Feasibility and acceptability of a peer influencer delivered social media based intervention to promote mental health awareness for young Black and Latinx gay and bisexual men and transgender women
Using an intervention informed and delivered by PIs, participants were presented with information to address relevant mental health concerns. We found that such novel means of engaging this sample for mental health is feasible, acceptable, and merits further development
Preliminary Evidence of the Association between Time on Buprenorphine and Cognitive Performance among Individuals with Opioid Use Disorder Maintained on Buprenorphine
People on buprenorphine maintenance treatment (BMT) commonly present cognitive deficits that have been associated with illicit drug use and dropout from buprenorphine treatment. This study has compared cognitive responses to the Stroop Task and the Continuous Performance Task (CPT) among individuals on BMT, with recent drug use, and healthy controls and explored the associations between cognitive responses and drug use, craving, and buprenorphine…
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on Covid-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C
Greater SDoH difficulties and lower self-efficacy were associated with greater inability to practice COVID-19 personal protective behaviors. Interventions to meet SDoH-related challenges and increase self-efficacy could help encourage practice of personal protective behaviors and economically reduce disease burden during health crises
Medicine (23 obras) · Psychiatry (17 obras) · HIV/AIDS Research and Interventions (14 obras) · HIV, Drug Use, Sexual Risk (11 obras) · Psychology (11 obras) · Internal Medicine (10 obras) · Clinical Psychology (9 obras) · Viral load (8 obras) · Drug (7 obras) · Family medicine (7 obras)